Lifeline scouts for M&A deals to expand market presence both in India, abroad

Lifeline Industries Ltd engaged in the manufacture of active pharmaceutical ingredients (APIs) and intermediates is aggressively scouting for promising mergers and acquisitions (M&A) as part of its inorganic growth strategy. It is now looking at units which can fit into its line of business both in India and abroad. 

Viewing opportunities in the market, the company under its organic growth efforts has also invested $50 million and is currently in the process of modernizing units at Bidar in north Karnataka, Solapur and Tarapur in Maharashtra to generate more capacities and also seek US FDA certification for its Mahad plant. 

Since Lifeline has made substantial investments in the last couple of years, it is now focused on a fast paced growth plan. M&As are done to synergize and increase scale of operation. Efforts are on to tap Africa, CIS, Latin America, Russia, Brazil which have good opportunity for growth. "We are gearing up for growth both through organic and inorganic paths. This is through constant expansion of capacities to offer new products besides scout for potential M&A deals", Nikunj Kanakia, chairman & managing director, Lifeline Industries